Glucose and lipid metabolism in patients with advanced pancreatic cancer receiving palliative chemotherapy

Anticancer Research

Volumn 33, Issue 1, 2013, Pages 287-292

  Zeiss, Katharina ^a   Parhofer, Klaus G ^a   Heinemann, Volker ^b,c   Haas, Michael ^b,c   Laubender, Rüdiger P ^d   Holdenrieder, Stefan ^b   Schulz, Christoph ^b,c   Boeck, Stefan ^b,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c German Cancer Consortium (DKTK)   (Germany)

^d NONE   (Germany)

Author keywords

Chemotherapy; Diabetes mellitus; Insulin; Pancreatic cancer

Indexed keywords

CHOLESTEROL; GLUCOSE; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; LIPID ANALYSIS; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; METASTASIS; MULTIMODALITY CANCER THERAPY; ONCOLOGICAL PARAMETERS; ORAL GLUCOSE TOLERANCE TEST; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DEOXYCYTIDINE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PILOT PROJECTS; PROGNOSIS;

EID: 84873030699     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F and Woodward M: Type-II diabetes and pancreatic cancer: A meta-analysis of 36 studies. Br J Cancer 92: 2076-2083, 2005.
3. Rosato V, Tavani A, Bosetti C, Pelucchi C, Talamini R, Polesel J, Serraino D, Negri E and La Vecchia C: Metabolic syndrome and pancreatic cancer risk: A case control study in Italy and metaanalysis. Metabolism 60: 1372-1378, 2011.
4. Li D: Diabetes and pancreatic cancer. Mol Carcinog 51: 64-74, 2012.
5. Pannala R, Basu A, Petersen GM and Chari ST: New-onset diabetes: A potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 10: 88-95, 2009.
6. Wang F, Herrington M, Larsson J and Permert J: The relationship between diabetes and pancreatic cancer. Mol Cancer 2: 4, 2003.
7. Pannala R, Leirness JB, Bamlet WR, Basu A, Petersen GM and Chari ST: Prevalence and clinical profile of pancreatic cancerassociated diabetes mellitus. Gastroenterology 134: 981-987, 2008.
8. Hsu IR, Kim SP, Kabir M and Bergman RN: Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr 86: 867-871, 2007.
9. Li W, Ma Q, Liu J, Han L, Ma G, Liu H, Shan T, Xie K and Wu E: Hyperglycemia as a mechanism of pancreatic cancer metastasis. Front Biosci 17: 1761-1774, 2012.
10. Han L, Ma Q, Li J, Liu H, Li W, Ma G, Xu Q, Zhou S and Wu E: High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. PLoS One 6: e27074, 2011.
11. Zyromski NJ, Mathur A, Pitt HA, Wade TE, Wang S, Nakshatri P, Swartz-Basile DA and Nakshatri H: Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery 146: 258-263, 2009.
12. Kang SP and Saif MW: Clinical outcome of pancreatic cancer patients with diabetes mellitus: Is diabetes a poor prognostic factor? JOP 11: 334-335, 2010.
13. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216, 2000.
14. Berster JM and Goke B: Type-2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem 114: 84-98, 2008.
15. Magruder JT, Elahi D and Andersen DK: Diabetes and pancreatic cancer: Chicken or egg? Pancreas 40: 339-351, 2011.
16. McWilliams RR, Matsumoto ME, Burch PA, Kim GP, Halfdanarson TR, de Andrade M, Reid-Lombardo K and Bamlet WR: Obesity adversely affects survival in pancreatic cancer patients. Cancer 116: 5054-5062, 2010.
17. Sadeghi N, Abbruzzese JL, Yeung SC, Hassan M and Li D: Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clin Cancer Res 18: 2905-2912, 2012.
18. Aggarwal G, Kamada P and Chari ST: Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers. Pancreas 2012 Sep 20 [Epub ahead of print]
19. Tisdale MJ: Cachexia in cancer patients. Nat Rev Cancer 2: 862-871, 2002.
20. Agustsson T, Ryden M, Hoffstedt J, van Harmelen V, Dicker A, Laurencikiene J, Isaksson B, Permert J and Arner P: Mechanism of increased lipolysis in cancer cachexia. Cancer Res 67: 5531-5537, 2007.